Kombucha Tea Prevents Obese Mice from Developing Hepatic Steatosis and Liver Damage
Authors:
Jeongeun Hyun, Youngjae Lee, Sihyung Wang, Jinnyun Kim, Jieun Kim, JaeHo Cha, Young-Su Seo, Youngmi Jung
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is associated with increased accumulation of hepatocellular lipids. Although Kombucha tea (KT) has emerged as a substance protecting the liver from damage, the effects of KT in NAFLD remain unclear. Hence, we investigated whether KT influenced hepatic steatosis. Db/db mice were fed either control or methionine/choline-deficient (MCD) diets for 4 weeks. The MCD diet group was treated with KT or water for 3 weeks. KT treatment alleviated macrovesicular steatosis compared to the MCD-fed group. The levels of triglyceride, ALT, and AST also decreased in the KT+MCD-treated db/db mice. RNA expression in the MCD+KT group showed reduced triglyceride synthesis and uptake of fatty acids. Immunostaining and western blot assays for active caspase-3 demonstrated a lower level of apoptosis in the MCD+KT than in the MCD group. These results demonstrate that KT attenuated lipid accumulation and protected the liver from damage, promoting liver restoration in mice.
Keywords: kombucha tea, nonalcoholic fatty liver disease, liver protection, db/db mouse
Country: Korea
Citation: Food science and biotechnology v.25 no.3 pp. 861-866
Study Mailing Address:
Department of Biological Sciences, Pusan National University, Pusan 46241, Korea
Date Updated: January 20, 2021
![Click here to like this study Thumbs Up](/wp-content/uploads/Thumbs-Up-32.png)